Regione del Veneto - AULSS n. 7 Pedemontana: Not applicable (device, behavioral) study in Sepsis, Septic Shock (430 participants)
Regione del Veneto - AULSS n. 7 Pedemontana: Not applicable (device, behavioral) study in Sepsis, Septic Shock (430 participants). Its enrollment of 430 is above the median of 80 (88th percentile). Dated 29 days ago, it is in the active follow-up window. Score 30/100. As of 2026-11-04, from ClinicalTrials.gov (U.S. National Library of Medicine) API v2.
Data as of · Compiled by Zalwin from ClinicalTrials.gov (U.S. National Library of Medicine) API v2
enrollment: 430 · 88th percentile of 8,879 ClinicalTrialStartPulse records · 5.4x the median
Free preview: all 14 published fields of this record are shown below. Locked: 499 related ClinicalTrialStartPulse records and the 7-column CSV export.
| Field | Value |
|---|---|
| Sponsor | Regione del Veneto - AULSS n. 7 Pedemontana |
| Sponsor type | Academic and hospital |
| Study | Non-invasive Hemodynamic Optimization of Sepsis in Internal Medicine: a Randomized Study Comparing Therapy Guided by Non-invasive Hemodynamic Indices Versus Standard of Care. |
| NCT ID | NCT07863323 |
| Phase | Not applicable (device, behavioral) |
| Status | recruiting |
| Conditions | Sepsis; Septic Shock |
| Intervention types | diagnostic test, other |
| Target enrollment | 430 |
| Site countries | Italy |
| Posted | 2026-10-07 |
| Planned start | 2025-06-03 |
| Event | Newly registered study |
| Event date | 2026-10-07 |
| enrollment percentile | 88th of 8,879 (median 80, 5.4x median) |
| Peer records CSV (500 records) | 🔒 Click to unlock → |
| CRM-ready export with official source URLs | 🔒 Click to unlock → |
Watch Regione del Veneto - AULSS n. 7 Pedemontana
Free email alert. Alert me when this company gets a new filing, lien, permit, contract or expiry in this feed. One confirmation email; unsubscribe any time.
Free for 1 company. More companies from $9/mo (25), $49/mo (500 + CSV), $199/mo (500 + CSV + API). Cancel any time from the link in every email.
Free first: a 10-record sample of records
See the real columns before you buy. One confirmation email, nothing else unless you opt in.
Unlock Regione del Veneto - AULSS n. 7 Pedemontana + 500 peer records (CSV)
Instant CSV download · Card, Apple Pay, Google Pay or Link via Stripe · No account required
CSV columns: Sponsor · Phase · Conditions · Enrollment · Countries · Event · Posted · official source URL
- Source agency: ClinicalTrials.gov (U.S. National Library of Medicine) API v2
- Record date: 2026-10-07
- Data refreshed: 2026-11-04
- Refunds on request within 14 days
Top ClinicalTrialStartPulse records (NONUS first): University of Oxford · DejthidaNathaphong · Eye & ENT Hospital of Fudan University · Shanghai First Maternal and Infant Health Hospital affiliate · Fondazione Policlinico Universitario Agostino Gemelli IRCCS · Browse all by state and category →
LIVE PUBLIC DATA Source: ClinicalTrials.gov (U.S. National Library of Medicine) API v2 · Last refreshed: Wed, 04 Nov 2026 06:04:38 GMT
Is this your business? Add a "Listed on Zalwin" badge to your site
Paste this snippet into your website. It links to this public record; nothing is tracked on your site.
Peer benchmark and outreach value: Regione del Veneto - AULSS n. 7 Pedemontana and 6,603 NONUS peers
- NONUS ClinicalTrialStartPulse records like this one: 6,603
- Regione del Veneto - AULSS n. 7 Pedemontana's enrollment: 88th percentile of 8,879 records
- Timing: Medium: dated in the last 30 days
- Estimated pipeline if you contact every NONUS peer: $1,320,600 (peers × rate × deal size; an estimate from your assumptions, not a forecast)
30 / 100 Score
- 430 participants planned.
What is the ClinicalTrialStartPulse record for Regione del Veneto - AULSS n. 7 Pedemontana?
Regione del Veneto - AULSS n. 7 Pedemontana registered a Not applicable (device, behavioral) study (NCT07863323) in Sepsis targeting 430 participants, posted 2026-10-07.
How does Regione del Veneto - AULSS n. 7 Pedemontana compare to other ClinicalTrialStartPulse records?
Its enrollment of 430 sits in the upper half (88th percentile) of 8,879 records; the median is 80. It is 29 days old, still within a typical 45-day follow-up window. Its Score of 30/100 is modest; treat it as background rather than a priority.
Regione del Veneto - AULSS n. 7 Pedemontana vs. top 3 peers
| Organization | Location | Amount | Percentile | Record date |
|---|---|---|---|---|
| Regione del Veneto - AULSS n. 7 Pedemontana | NONUS | 430 | 88th | 2026-10-07 |
| Galderma R&D | NONUS | 326 | 84th | 2026-11-02 |
| Galderma R&D | NONUS | 162 | 72nd | 2026-11-03 |
| A.M.I. Agency for Medical Innovations GmbH | NONUS | 100 | 60th | 2026-10-30 |
Related records
ClinicalTrialStartPulse: Not applicable (device, behavioral) ClinicalTrialStartPulse: Outside the US only
How to monitor Regione del Veneto - AULSS n. 7 Pedemontana and peer not applicable (device, behavioral) records
Get new ClinicalTrialStartPulse records like Regione del Veneto - AULSS n. 7 Pedemontana by email (free, weekly)
We email one confirmation link now; the weekly digest starts only after you confirm. One-click unsubscribe in every email.
Double opt-in: nothing is sent until you click the confirmation link. One-click unsubscribe.
Get new studies in your therapeutic areas
ClinicalTrialStartPulse emails new studies and status changes matching your events, phases, sponsor types and site regions.
✓ Read-only, live public data · Key and unlock right after payment · Card, Apple Pay, Google Pay or Link via Stripe · Refunds on request within 14 days
From public ClinicalTrials.gov registrations. Sponsor and study level only: we never list investigators, contacts or participants. A registration describes a planned study and can change. Status changes are read from each study's current status, actual dates and latest posted update, not a full change history, so an update can be a correction rather than a new change. Verify on ClinicalTrials.gov.